# Steven O’Day

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/steven-o-day/

## Facts

| Field | Value |
| --- | --- |
| Citations | 47,785 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 65 |
| i10-index | 150 |
| OpenAlex ID | https://openalex.org/A5060495866 |
| ORCID iD | https://orcid.org/0009-0005-5345-5417 |
| Works | 421 |

## Researcher papers

- [Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma](https://scholariq.org/papers/ipilimumab-plus-dacarbazine-for-previously-untreated-metastatic-melanoma/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.